{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:35:13Z","timestamp":1792427713147,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16810055"],"award-info":[{"award-number":["16810055"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015060","name":"Nagasaki University","doi-asserted-by":"publisher","award":["2021\\u201302"],"award-info":[{"award-number":["2021\\u201302"]}],"id":[{"id":"10.13039\/100015060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clim.2023.109846","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T05:35:41Z","timestamp":1700717741000},"page":"109846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Efficacy and safety of 5-aminolevulinic acid in adult-onset Still's disease: A preclinical study in mice and a pilot study in humans"],"prefix":"10.1016","volume":"257","author":[{"given":"Tomohiro","family":"Koga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshika","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2023.109846_bb0005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still\u2019s disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2023.109846_bb0010","article-title":"Adult-onset Still\u2019s disease: a disease at the crossroad of innate immunity and autoimmunity","volume":"9","author":"Rao","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.clim.2023.109846_bb0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13075-019-1843-9","article-title":"Efficacy of canakinumab as first-line biologic agent in adult-onset Still\u2019s disease","volume":"21","author":"Cavalli","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2023.109846_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152139","article-title":"Systematic review on the use of biologics in adult-onset still\u2019s disease","volume":"58","author":"Fautrel","year":"2023","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.clim.2023.109846_bb0025","doi-asserted-by":"crossref","first-page":"F1149","DOI":"10.1152\/ajprenal.00275.2013","article-title":"5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury","volume":"305","author":"Hou","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.clim.2023.109846_bb0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.healun.2014.09.037","article-title":"5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells","volume":"34","author":"Hou","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.clim.2023.109846_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1172\/JCI4165","article-title":"Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency","volume":"103","author":"Yachie","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2023.109846_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/MPH.0b013e3181fd2aae","article-title":"Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia","volume":"33","author":"Radhakrishnan","year":"2011","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.clim.2023.109846_bb0045","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/14397595.2017.1422231","article-title":"Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still\u2019s disease: a multicenter retrospective study","volume":"28","author":"Kirino","year":"2018","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.clim.2023.109846_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2018.05.009","article-title":"Oral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron","volume":"833","author":"Ito","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.clim.2023.109846_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12865-018-0277-5","article-title":"5-Aminolevulinic acid regulates the immune response in LPS-stimulated RAW 264.7 macrophages","volume":"19","author":"Sugiyama","year":"2018","journal-title":"BMC Immunol."},{"key":"10.1016\/j.clim.2023.109846_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.animal.2022.100575","article-title":"Effects of 5-aminolevulinic acid on the inflammatory responses and antioxidative capacity in broiler chickens challenged with lipopolysaccharide","volume":"16","author":"Chen","year":"2022","journal-title":"Animal"},{"key":"10.1016\/j.clim.2023.109846_bb0065","article-title":"Effects of oral 5-aminolevulinic acid on lipopolysaccharide-induced ocular inflammation in rats","volume":"10","author":"Otaka","year":"2023","journal-title":"Vet. Sci."},{"key":"10.1016\/j.clim.2023.109846_bb0070","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/rheumatology\/keac381","article-title":"Inhibition of calcium\/calmodulin-dependent protein kinase IV in arthritis: dual effect on Th17 cell activation and osteoclastogenesis","volume":"62","author":"Koga","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2023.109846_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.106.101113","article-title":"(5R)-5-hydroxytriptolide attenuated collagen-induced arthritis in DBA\/1 mice via suppressing interferon-gamma production and its related signaling","volume":"318","author":"Zhou","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.clim.2023.109846_bb0080","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022708","article-title":"Single-arm, open-label pilot intervention study to investigate an effect of oral 5-aminolevulinic acid plus sodium ferrous citrate on glucocorticoid reduction in patients with adult-onset Still disease: study protocol for clinical trial (SPIRIT compliant)","volume":"99","author":"Sumiyoshi","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2023.109846_bb0085","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2023.109846_bb0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/clin.1994.1164","article-title":"Collagen-induced arthritis as a model of rheumatoid arthritis","volume":"73","author":"Durie","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2023.109846_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1353-6","article-title":"Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis","volume":"19","author":"Lee","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2023.109846_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1224-1","article-title":"Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker","volume":"19","author":"Pandya","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2023.109846_bb0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1517\/14728222.12.2.171","article-title":"Pro-inflammatory cytokine-induced SAPK\/MAPK and JAK\/STAT in rheumatoid arthritis and the new anti-depression drugs","volume":"12","author":"Malemud","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.clim.2023.109846_bb0110","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000160","article-title":"Intracellular signaling pathways in rheumatoid arthritis","volume":"4","author":"Malemud","year":"2013","journal-title":"J. Clin. Cell Immunol."},{"key":"10.1016\/j.clim.2023.109846_bb0115","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still\u2019s disease","volume":"30","author":"Choi","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2023.109846_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-02200-4","article-title":"Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still\u2019s disease from sepsis","volume":"22","author":"Koga","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2023.109846_bb0125","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","article-title":"Elevated serum levels of free interleukin-18 in adult-onset Still's disease","volume":"55","author":"Girard","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2023.109846_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020905","article-title":"Rheumatoid arthritis: pathogenic roles of diverse immune cells","volume":"23","author":"Jang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2023.109846_bb0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.abb.2014.09.005","article-title":"Heme oxygenase-1 and anti-inflammatory M2 macrophages","volume":"564","author":"Naito","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.clim.2023.109846_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.953730","article-title":"Activation mechanisms of monocytes\/macrophages in adult-onset Still disease","volume":"13","author":"Tsuboi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2023.109846_bb0145","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015123","article-title":"Managing adult-onset Still\u2019s disease: the effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study","volume":"98","author":"Ruscitti","year":"2019","journal-title":"Medicine"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623006101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661623006101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:43:33Z","timestamp":1778816613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661623006101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":29,"alternative-id":["S1521661623006101"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2023.109846","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of 5-aminolevulinic acid in adult-onset Still's disease: A preclinical study in mice and a pilot study in humans","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2023.109846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109846"}}